Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 11
Original Research
Budget Impact Of Including Avelumab As A Second-Line Treatment For Locally Advanced Or Metastatic Urothelial Cancer In The United States: Commercial And Medicare Payer Perspectives
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,710 | Dovepress* | 8,782+ | 1,152 | 9,934 | |
| PubMed Central* | 928 | 234 | 1,162 | ||
| Totals | 9,710 | 1,386 | 11,096 | ||
| *Since 8 November 2019 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 7 | 0 | 0 | 0 | 2 | 5 |
View citations on PubMed Central and Google Scholar